An artificial intelligence company has established a physical biology laboratory as it expands its work in life sciences and potential drug development. The facility allows researchers to carry out real world biological experiments alongside computer based AI research.

The company says physical laboratory work remains an important part of understanding biology and developing new scientific approaches. It is also exploring ways for AI systems to work with robotic equipment while keeping human involvement in the process.

The broader programme is focused on using artificial intelligence to accelerate research into diseases and conditions that have received less attention from traditional drug development efforts. The company is still in the early stages of this work, and any future medicines would require extensive testing before reaching patients.